Open AccessMalignant Hyperthermia: Management without DANTROLENE
Author(s) -
Sobia Manzoor,
Syed Amer Zahoor,
Jan Mohammad Rather
Publication year - 2018
Publication title -
journal of medical sciences/journal of medical sciences (srinagar. online)
Language(s) - English
Resource type - Journals
eISSN - 2582-063X
pISSN - 0972-110X
DOI - 10.33883/jms.v21i1.332
Subject(s) - dantrolene , malignant hyperthermia , medicine , anesthesia , hyperthermia , dantrolene sodium , gold standard (test) , surgery , calcium
Malignant Hyperthermia(MH) is a hypermetabolic syndrome which is quite rare in India. Inhalational anesthetics and succinyl choline have been reported as potent triggering agents of MH. Dantrolene remains the gold standard for treating this life-threatening syndrome.
We encountered a case of malignant hyperthermia in a 34-year-old male undergoing ventricular septal defect closure under general anesthesia. We successfully managed our patient by timely recognition of this syndrome and by administering prompt, effective symptomatic treatment and without dantrolene which was not available in our hospital. JMS 2018;21(1):40-43